Page 60 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon
P. 60

1522_C01.fm  Page 47  Tuesday, December 2, 2003  10:05 AM









                              145. Colado, M.I., Granados, R., O’Shea, E., Esteban, B., and Green, A.R., The
                                   acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, “eve”) on
                                   body temperature and long term degeneration of 5-HT neurones in brain: a
                                   comparison with MDMA (“ecstasy”), Pharmacol. Toxicol., 84, 261, 1999.
                              146. Morland, J., Toxicity of drug abuse — amphetamine designer drugs (ecstasy):
                                   mental effects and consequences of single dose use, Toxicol. Lett., 112–113,
                                   147, 2000.
                              147. Curran, H.V., Is MDMA (“Ecstasy”) neurotoxic in humans? An overview of
                                   evidence and of methodological problems in research, Neuropsychobiology,
                                   42, 34, 2000.
                              148. Chang, L., Grob, C.S., Ernst, T., Itti, L., Mishkin, F.S., Jose-Melchor, R., and
                                   Poland, R.E., Effect of ecstasy [3,4-methylenedioxymethamphetamine
                                   (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study,
                                   Psychiatry Res., 98, 15, 2000.
                              149. Ernst, T., Chang, L., Leonido-Yee, M., and Speck, O., Evidence for long-term
                                   neurotoxicity associated with methamphetamine abuse: A 1H MRS study,
                                   Neurology, 54, 1344, 2000.
                              150. Hervias, I., Lasheras, B., and Aguirre, N., 2-Deoxy-D-glucose prevents and
                                   nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced
                                   serotonin neurotoxicity, J. Neurochem., 75, 982, 2000.
                              151. Kish, S.J., Furukawa,  Y.,  Ang, L.,  Vorce, S.P., and Kalasinsky, K.S., Striatal
                                   serotonin is depleted in brain of a human MDMA (Ecstasy) user, Neurology,
                                   55, 294, 2000.
                              152. Ricaurte, G.A.,  Yuan, J., and McCann, U.D., (+/-)3,4-methylenedioxy-
                                   methamphetamine (“Ecstasy”)-induced serotonin neurotoxicity: studies in
                                   animals, Neuropsychobiology, 42, 5, 2000.
                              153. Bai, F., Jones, D.C., Lau, S.S., and Monks, T.J., Serotonergic neurotoxicity of
                                   3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylen-
                                   dioxymethamphetamine (“Ecstasy”) is potentiated by inhibition of gamma-
                                   glutamyl transpeptidase, Chem. Res. Toxicol., 14, 863, 2001.
                              154. Buchert, R., Obrocki, J., Thomasius, R., Vaterlein, O., Petersen, K., Jenicke,
                                   L., Bohuslavizki, K.H., and Clausen, M., Long-term effects of “ecstasy” abuse
                                   on the human brain studied by FDG PET, Nucl. Med. Commun., 22, 889, 2001.
                              155. Cadet, J.L., Thiriet, N., and Subramanian, J., Involvement of free radicals in
                                   MDMA-induced neurotoxicity in mice, Ann. Med. Interne (Paris), 152 Suppl.
                                   3, 57, 2001.
                              156. Nixdorf, W.L., Burrows, K.B., Gudelsky, G.A., and Yamamoto, B.K., Enhance-
                                   ment of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy
                                   inhibitor malonate, J. Neurochem., 77, 647, 2001.
                              157. Moeller, M.R. and Hartung, M., Ecstasy and related substances — serum
                                   levels in impaired drivers [letter; comment], J. Anal. Toxicol., 21, 591, 1997.



                             © 2004 by CRC Press LLC
   55   56   57   58   59   60   61   62   63   64   65